Archive - March 2018
Judge orders 1,200 Xarelto liability cases to be prepped for trials
News from other sources
Despite FDA concerns, Pfizer’s Xeljanz wins unanimous AdComm backing in ulcerative colitis
Sanofi says DOJ foreign bribery probe is over but discussions with SEC ongoing
Johnson & Johnson’s $15B in 2017 discounts lead to negative price change, but are consumers benefiting?
FiercePharmaAsia—Merck-Eisai’s Lenvima deal, JW’s $90M series A, novel HIV drug
MSD launches EU’s first biosimilar Herceptin in UK
Novartis pushes ‘virtual’ clinical trial concept